In addition to the attenuated production of mtROS and cellular ROS that we now identify in LACC1 risk carriers, decreased ROS production has been observed with NADPH oxidase complex variants associated with early-onset IBD4, and with chronic granulomatous disease, a disease in which a substantial percentage of individuals develop intestinal inflammation5. The gene discussed is LACC1; the disease is chronic granulomatous disease.